Purpose. The aim of this study was to investigate whether metastatic colorectal cancer (Union for International Cancer Control stage IV disease) represents a risk factor for anastomotic leakage after colorectal surgery without major hepatic resection.
Conclusions. Patients with stage IV colorectal cancer have an increased anastomotic leak rate after colorectal surgery. Whether this is due to an impaired immune system remains speculative.
One in five patients with diagnosed colorectal cancer has synchronous liver metastasis and only a minority qualify for curative liver resection. 1 Different treatment strategies in the palliative and curative setting are under debate; [2] [3] [4] [5] [6] [7] [8] however, surprisingly little is known of the specific risks of colorectal surgery in patients with metastatic colorectal cancer.
We aimed to determine if metastatic colorectal cancer [Union for International Cancer Control (UICC) stage IV disease] itself represents a risk factor for anastomotic leakage after colonic or rectal anastomosis without major hepatic resection, and to compare it with other known risk factors of anastomotic leakage.
METHODS
This retrospective cohort study was based on an existing prospective colorectal database of all consecutive colorectal resections undertaken at the authors' institution from July 2002 to July 2012 (n = 2104). As different hospitals were located near the authors' institution, the study was not population-based. Patients with colorectal resections without colonic or rectal anastomosis (n = 229) were excluded. From the remaining 1875 patients, those with the following procedures were excluded: reversal of Hartmann's procedure (n = 70); redo of anastomosis for anastomotic leak (n = 7); colon resection and primary anastomosis for the following diseases: diverticular disease (n = 661), colorectal adenoma (n = 111), rectal prolapse (n = 122), noncolorectal cancer (n = 101), complicated appendicitis (n = 63), chronic inflammatory bowel disease (n = 58), ischemic or infectious colitis (n = 44), iatrogenic or traumatic colon perforation (n = 37), nonmalignant large bowel obstruction (including anastomotic stenosis, radiation injuries, incarcerated hernia; n = 30), slow-transit constipation (n = 22), volvulus (n = 11), Ogilvie's syndrome with severe colonic damage (n = 10), colonic bleeding (n = 22), and other reasons (n = 6). Finally, 500 patients with colorectal resection and primary anastomosis for colorectal cancer were included in the study.
The routine preoperative work-up comprised computed tomography (CT) scan of the abdomen, and conventional X-ray or CT scan of the thorax. In the case of suspicion of liver metastasis, magnetic resonance imaging (MRI) and intraoperative ultrasound were undertaken.
A temporary loop ileostomy was always constructed in low rectal anastomosis up to 6 cm from the anal verge (n = 128 cases, 26 %).
The laboratory values measured 1 day before surgery were assessed. Extravasation of water-soluble contrast medium in conventional contrast enema or CT scan, abscesses near the colonic or rectal anastomosis without extravasation of contrast medium, and anastomotic leaks diagnosed during surgical re-intervention in the presence of obvious signs of an anastomotic leak, such as fecal abdominal drainage, were accounted for as anastomotic leaks. Patients were observed clinically and by routine inflammation markers during hospitalization for several days. However, in the case of unexpected postoperative course after sending patients home, they were reliably sent back to the present surgical unit for further treatment.
Routine contrast enema was undertaken at the occasion of other prospective studies (n = 254), especially in all patients with temporary loop ileostomy (n = 131). In the remaining patients (n = 246), CT or conventional contrast enema was only undertaken in the case of suspicion of an anastomotic leak.
UICC stage IV disease was present in 94 patients (19 %), while 406 patients (81 %) had UICC stage I-III disease. An overview of the study methodology is shown in Fig. 1 .
Statistics
Results are expressed as median and range or mean and standard deviation whenever appropriate. Categorical data were analyzed using the two-sided Fisher's exact test and Pearson's Chi square test if the contingency table was larger than 2 9 2. Continuous data were analyzed using the Wilcoxon rank sum test. Multivariate analyses were undertaken by logistic regression, and p values \0.05 were considered statistically significant.
Ethics Statement
The present study was a retrospective observational study without any experimental protocols, and thus no potential harm for patients.
RESULTS
The only significant difference in characteristics between patients with stage I-III and patients with stage IV colorectal cancer was the American Society of Anesthesiologists (ASA) score, as shown in Table 1 . The distribution of metastases in patients with metastatic disease (n = 94) was 49 % (n = 46) liver only, 3 % (n = 3) lung only, 3 % (n = 3) peritoneal only, 3 % (n = 3) retroperitoneal only, 12 % (n = 11) liver and lung only, 12 % (n = 11) peritoneal and liver only, 1 % (n = 1) retroperitoneal and lung only, and 17 % (n = 16) multiorgan disease.
Overall, 42.5 % (n = 40) of patients with metastatic disease were treated with a curative intent, while 41.5 % (n = 39) had planned palliative therapy and the remaining 16 % (n = 15) had palliative best-supportive care due to their poor general state.
The anastomotic leaks were diagnosed on median postoperative day 6 (range 1-15), and the overall anastomotic leak rate was 2.6 % (13/500). Two of these 13 anastomotic leaks were diagnosed by routine contrast enema and remained subclinical (i.e., without symptoms), two were managed conservatively, and nine required revision laparotomy.
It is noteworthy that three of the six patients with stage IV colorectal cancer who had anastomotic leakage were in a palliative setting.
The analyzed and detected risk factors for the development of an anastomotic leak after resection of colon or rectal cancer (univariate) are shown in Table 2 , and the results of the multivariate analyses comparing the detected risk factors for the development of an anastomotic leak Table 3 ; stage IV colorectal cancer and diabetes remained statistically significant risk factors for the development of an anastomotic leak, while male sex and resection of leftsided colon cancer or rectal cancer did not.
The leak rate of patients with and without UICC stage IV colorectal cancer is depicted in Fig. 2 ; the leak rate was 9 % (6/63) in patients with diabetes mellitus and 1.6 % (7/ 437) without.
Subgroup Analyses: Colon Cancer
From 339 patients with colon cancer, 10 had anastomotic leakage (2.9 %). With respect to the type of surgery, leak rates were as follows: left hemicolectomy, 8/137 (6.7 %); subtotal colectomy, 1/31; transverse resection, 0/ 5; right hemicolectomy 1/166 (0.6 %).
Univariate analysis revealed that stage IV disease (p = 0.006), left colon cancer (p = 0.010), and male sex (p = 0.023) were statistically significant predictors of anastomotic leakage after resection of colon cancer, while the other analyzed factors were not. Multivariate analyses with the detected significant predictors of anastomotic leakage showed that stage IV disease [odds ratio (OR) 7.6, 95 % confidence interval (CI) 2.0-29.4; p = 0.003], leftsided colon cancer (OR 11.1, 95 % CI 1.3-91.8; p = 0.025), and male sex (OR 8.7, 95 % CI 1.0-71.5; p = 0.045) remained independent statistically significant predictors of anastomotic leakage after resection of colon cancer.
Subgroup Analyses: Rectal Cancer
From 161 patients with rectal cancer, three had anastomotic leakage (1.9 %). In patients with high anterior rectosigmoid resection with partial mesorectal excision without loop ileostomy for cancer of the upper third of the rectum (n = 30) no leak occurred, while in those patients with low anterior rectal resection with loop ileostomy for cancer of the lower two-thirds of the rectum (n = 128) or with high anterior rectosigmoid resection with loop ileostomy (n = 3) the leak rate was 2.3 % (3/131).
Univariate analysis revealed that diabetes (p = 0.001) and a lower preoperative hemoglobin value (p = 0.023) were statistically significant predictors of anastomotic leakage, while the other analyzed factors were not. Multivariate analyses with the two detected significant predictors of anastomotic leakage showed that diabetes (OR 7.7E8, 95 % CI 11.9E3-5.0E13; p \ 0.001) remained a statistically significant predictor of anastomotic leakage, while a lower preoperative hemoglobin value (OR 0.5, 95 % CI 0.2-1.3; p = 0.143) did not.
DISCUSSION Surprisingly, little is known about the risks of colorectal surgery in patients with metastatic colorectal cancer. This study shows that metastatic colorectal cancer (UICC stage IV disease) itself is a risk factor for anastomotic leakage after colorectal surgery without major hepatic resection. Is this finding plausible? First, it is known that liver metastasis leads to an altered immune response. 9, 10 Immunosuppression, as induced by steroids, is a well-known risk factor for the development of an anastomotic leak after colorectal surgery. 11 Second, up to 65 % of patients with grade IV colorectal cancer have malnutrition, 12 and patients with malnutrition also have an altered immune response with an exaggerated interleukin (IL)-6 and a suppressed IL-1 response. 13, 14 A low level of IL-1 receptor antagonist is a known risk factor for adverse outcome after colorectal surgery. 15 In addition to metastatic colorectal cancer as a risk factor for anastomotic leakage, diabetes was identified as a 18 and thus it can also be assumed to be a risk factor for anastomotic leakage after colorectal surgery. Indeed, some studies identified diabetes as a risk factor for anastomotic leakage after colorectal surgery, 19, 20 while others did not. 21, 22 Subgroup analyses revealed that in this study diabetes only remained a risk factor for anastomotic leakage in patients with rectal cancer; however, further research is needed to confirm whether or not diabetes is a risk factor for anastomotic leakage after colorectal surgery. Subgroup analyses of those patients with resection of left-sided colon cancer had a significantly higher leakage rate than those with right-sided colorectal cancer, as known from the literature. 16, 17 We drew the conclusion that the construction of a temporary loop ileostomy should be considered in patients with left-sided stage IV colon cancer.
Subgroup analyses also identified male sex as a significant risk factor for anastomotic leakage in patients with resection for colon cancer, as known from the literature. 23 
LIMITATIONS
The treatment policy for patients with stage IV colorectal cancer was to carry out the colorectal resection if feasible and safe. As mentioned above, the study is not population-based; thus, a patient selection bias with a selection of those patients in a better general state is possible. However, if more patients in a worse general state with an expected higher leakage rate would have been included, it can be assumed that stage IV disease would have turned out to be an even stronger predictor of anastomotic leakage.
As only approximately half of the patients were investigated by routine radiology (n = 254), few subclinical anastomotic leaks could have been missed in those patients who did not have routine radiology (n = 246). As one of the two patients with a subclinical leak had stage I cancer and the other had stage IV cancer, a bias is not expected.
This study had a retrospective design; thus, further bias cannot be excluded. However, a bias was minimized by including all consecutive patients registered in a prospective database who had colorectal resection at the same institution in a predefined period of 10 years.
To confirm the results of this study and to prove the value of a routine temporary loop ileostomy in patients with left-sided stage IV colon cancer, a prospective, randomized trial is required.
CONCLUSION
Patients with stage IV colorectal cancer have an increased leak rate after colonic or rectal anastomosis. Whether this is due to an impaired immune system remains speculative. 
